Hormonal Contraceptive Market Growing Trends and Business Opportunities by 2023

Government initiatives to promote awareness of the benefits of family planning and contraception, and advances in hormonal contraceptive techniques and methods for improving efficiency and developing products with fewer side effects, are key drivers of market growth.

Hormonal Contraceptive Market is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023.

North America is the highest contributor in the hormonal contraceptive market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Hormonal contraception acts on the endocrine system to prevent unwanted pregnancy. Synthetic forms of naturally occurring hormones such as progestin and estrogen are used to prevent ovulation and avoid fertilization. These forms of birth control methods also change the environment of the uterus, making it unfavorable for fertilization.

Hormonal contraceptives are available in a variety of forms such as patches, pill, injection, and rings, which are safe and reliable forms of hormonal contraceptives to prevent pregnancy.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4574

The major driving factors of the hormonal contraceptive market are an increase in focus towards family planning, health issues associated with teenage pregnancies, an increase in awareness about modern contraception methods, and a rise in the use of oral pills as a key method to prevent unplanned pregnancy.

The advancement in hormonal contraception with better efficacy and fewer side effects further boost the market growth. However, the availability of alternative contraceptive methods, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect market growth.

Among the product, the oral contraceptive pill is the dominant segment, as these pills are easily available and have a high success rate of up to 99% to prevent pregnancy. However, the vaginal ring registers the highest growth rate, due to the ease of usage and fewer side effects caused by it.

Combined hormonal contraceptive is the dominant segment in the hormonal contraceptive market, due to the wide availability of combined hormonal contraceptive along with better efficiency to prevent pregnancy.

In 2016, North America was the major revenue generator, owing to an increase in awareness towards the benefits of using hormonal contraceptives, high prevalence of unwanted pregnancy, and favorable regulatory scenario.

However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, due to the presence of populace countries such as India and China where there is a greater need to control the growing population.

The key players operating in the global hormonal contraceptive market include the Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.

Other prominent players in the value chain include Reckitt Benckiser Plc., Warner Chilcott Company, BioSante Pharmaceuticals Inc., HLL Lifecare Limited, Boehringer Ingelheim GmbH, Watson Pharmaceuticals, Inc., V-Care Pharma Pvt. Ltd., Vardhman Life Care Pvt. Ltd., Cipla Limited, and others.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4574

Key Findings of the Hormonal Contraceptive Market:
o Vaginal rings are projected to grow at the highest rate during the analysis period.
o North America dominated the global hormonal contraceptive market in 2016 and is projected to continue its dominance in the future.
o China is expected to grow at the highest rate in the Asia-Pacific region during the forecast period.
o Hospitals are the largest contributor among the end-user segments in 2016.
o The 15-24 years age group segment generated the highest revenue and is expected to continue its dominance in the future.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

help@alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.